• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

nContact Inc.

AtriCure closes $99m nContact buy

October 14, 2015 By Brad Perriello

AtriCure (NSDQ:ATRC) said yesterday that it closed the $99 million cash-and-stock buyout of cardiac ablation device maker nContact. Morrisville, N.C.-based nContact makes a system that’s designed to combine vacuum suction, perfusion and radiofrequency ablation to improve contact between cardiac tissue and the device. The company is running a U.S. investigational device exemption trial, comparing its Convergent procedure using the […]

Filed Under: Cardiovascular, Mergers & Acquisitions, Wall Street Beat Tagged With: AtriCure Inc., nContact Inc.

AtriCure picks up MIS cardiac company nContact

October 5, 2015 By Fink Densford

AtriCure (NSDQ:ATRC) said yesterday it bought cardiac-focused medical device developer nContact for approximately $99 million in shares of common stock and up front cash. The sale was funded with an upfront payment of approximately 3.7 million shares of AtriCure at $24.60 per share and $8 million in cash up front. The purchase also includes up to $50 million […]

Filed Under: Business/Financial News, Cardiovascular, Mergers & Acquisitions Tagged With: AtriCure Inc., nContact Inc.

Biolase CEO succession continues | Personnel Moves

July 21, 2015 By Fink Densford

Biolase (NSDQ:BIOL) said earlier this month that CEO Jeffery Nugent has resigned from both his position as CEO and the board of directors, effective July 12, to be replaced by Harold Flynn. Irvine, Calif.-based Biolase picked up Flynn, the former president of Zimmer Dental (NYSE:ZMH), in May to replace Nugent, who the company said had stepped in to […]

Filed Under: Business/Financial News Tagged With: Biolase, Iluminoss, iRhythm Technologies Inc., nContact Inc., Nuance Communications Inc., Personnel Moves, SANUWAVE Health Inc., Smartrac, Theralase, Zimmer Biomet

Atrial fibrillation: nContact wins FDA clearance for cardiac device

January 23, 2013 By MassDevice staff Leave a Comment

nContact logo

nContact said it’s received FDA clearance for modifications made to its cardiac ablation device.

The Research Triangle Park, N.C.-based device medical device company won 510(k) clearance from the federal watchdog agency for the next generation of its VisiTrax cardiac ablation device, EPi-Sense. The company says this product includes new sensors, generating electrical feedback to assist electrophysiologists with device positioning during cardiac ablation procedures.

Filed Under: News Well Tagged With: Ablation, Cardiac Rhythm Management, nContact Inc.

iRobot invests $6M into telemedicine company | Funding Roundup

February 2, 2012 By MassDevice staff Leave a Comment

iRobot
InTouch Health

iRobot Corp. (NSDQ: IRBT), famous for their Roomba automated cleaning robots, invested $6 million and launched an extended partnership with InTouch Health, which develops telemedicine systems for providing remote health care.

The venture builds on an existing relationship that the companies announced last summer, under which the companies engaged in a development and licensing agreement.

Filed Under: Funding Roundup, News Well Tagged With: Athersys Inc., CartiHeal Ltd., Checkpoint Surgical, Dana-Farber Cancer Institute, EDAP TMS SA, InterValve Inc., InTouch Health, iRobot, Joslin Diabetes Center, Mevion Medical Systems, nContact Inc., ProUroCare Medical Inc., Remote Patient Monitoring, S.E.A. Medical Systems Inc., SpectraScience Inc., Synchro Medical Solutions, Venture Capital/Private Equity

Optos gains on Project Daytona FDA clearance | MassDevice.com Regulatory Roundup

August 31, 2011 By MassDevice staff Leave a Comment

Optos

Shares of Optos plc (LSE:OPTS) gained 6.4 percent after the company announced that the FDA granted 510(k) clearance in the U.S. for its Project Daytona retinal scanning device.

The British ophthalmology device maker’s stock closed at £1.62 today (about $2.64), up about 15 cents since August 25, the day before the clearance announcement, when OPTS shares closed at £1.52 ($2.49) on the London Stock Exchange.

Filed Under: News Well, Optical/Ophthalmic Tagged With: AirXpanders, Biotronik, Masimo, Mauna Kea Technologies, nContact Inc., Optos Inc., Regulatory Roundup, Toshiba, Vexim

DePuy lands 510(k) for knee implant customization system | Regulatory Roundup

August 19, 2011 By MassDevice staff Leave a Comment

DePuy

DePuy Orthopaedics Inc. landed clearance for its TruMatch surgical customization system for use with its Sigma fixed-bearing knee replacement device.

That means the Warsaw, Ind.-based Johnson & Johnson (NYSE:JNJ) subsidiary no longer has to worry about the FDA’s past warnings over illegal marketing of the device on its website.

Filed Under: News Well Tagged With: depuysynthes, Johnson and Johnson, Knees, nContact Inc., WideMed Ltd.

nContact lops off ‘Surgical’ to reflect less invasive tech

January 11, 2011 By MassDevice staff Leave a Comment

nContact logo

nContact Surgical Inc. is now nContact Inc.

The Morrisville, N.C.-based cardiac device manufacturer said its new name represents a move towards less invasive, endoscopic approaches for treating irregular heartbeat with epicardial ablation. The company’s surgical tools allow cardiologists to treat arrhythmias through a small midline abdominal incision, according to the company.

Filed Under: Business/Financial News, News Well Tagged With: Cardiac Rhythm Management, nContact Inc.

nContact Surgical raises $16 million Series D round

November 12, 2010 By MedCity News Leave a Comment

MedCity News logo

Research Triangle Park, N.C.-based medical device maker nContact Surgical Inc. raised $16 million for its endoscopic cardiac ablation system that could enable doctors to treat the most difficult atrial fibrillation patients.

Filed Under: Business/Financial News, News Well Tagged With: Cardiac Rhythm Management, nContact Inc.

Primary Sidebar

DeviceTalks Weekly

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS